Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) — Equity Research

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) equity research: fundamental analysis, analyst coverage context, trend regime, RSI and 1M/3M returns. Free research summary for NSE/BSE market investors.

Sun Pharma is India's largest pharma company with US generics, branded formulations and specialty products.

About Sun Pharmaceutical Industries Limited Equity Research

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) trades on the NSE in India (NSE/BSE). This page provides a equity research view including equity research, analyst report, fundamental analysis signals, computed in real time from live market data. Data updates every 30 seconds. Currency shown in ₹ (INR).

Full SUNPHARMA.NS Quote Page →Explore Other Symbols India Screener Earnings Calendar

Frequently Asked Questions — Sun Pharma stock

What drives Sun Pharma's revenue?

US specialty product launches (Ilumya, Winlevi, Cequa), India branded generics growth and EBITDA margin improvement are the key Sun Pharma metrics.

How do I value Sun Pharma?

Forward P/E relative to Dr. Reddy's, Cipla and the Nifty Pharma index is the standard benchmark for Sun Pharma valuation.

Related India Stocks — Equity Research

RELIANCE.NS Equity Research TCS.NS Equity Research INFY.NS Equity Research HDFCBANK.NS Equity Research ICICIBANK.NS Equity Research WIPRO.NS Equity Research

More SUNPHARMA.NS Analysis

SUNPHARMA.NS AI Summary SUNPHARMA.NS Valuation SUNPHARMA.NS Price Targets SUNPHARMA.NS Strategic Opportunities SUNPHARMA.NS Trend SUNPHARMA.NS Sector Rotation SUNPHARMA.NS Quarterly Results SUNPHARMA.NS Profit & Loss SUNPHARMA.NS Balance Sheet SUNPHARMA.NS Cash Flow SUNPHARMA.NS Ratios

300x250